Registered Trials
-
NCT05231369
Phase 1/2Thailand
Total Enrollment: 60
Official Trial Registration:
-
NCT04566276
Phase 1/2Thailand
Total Enrollment: 96
Official Trial Registration:
Vaccine Type: RNA
This vaccine may also be referred to as ChulaCov19-US
This vaccine has reached Phase 2 trials.
There are no trials for this phase.
This vaccine is not yet approved.
Thailand
Total Enrollment: 60
Thailand
Total Enrollment: 96
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.